CR8577A - Derivados de coumarina y su uso - Google Patents

Derivados de coumarina y su uso

Info

Publication number
CR8577A
CR8577A CR8577A CR8577A CR8577A CR 8577 A CR8577 A CR 8577A CR 8577 A CR8577 A CR 8577A CR 8577 A CR8577 A CR 8577A CR 8577 A CR8577 A CR 8577A
Authority
CR
Costa Rica
Prior art keywords
optionally substituted
ring
hydrocarbon group
carboxyl group
linear
Prior art date
Application number
CR8577A
Other languages
English (en)
Inventor
Marui Shogo
Ogino Masaki
Tawada Hiroyuki
Yabe Osamu
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of CR8577A publication Critical patent/CR8577A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a una sal de metal alcalinoterrea o una sal de amina organica de un compuesto representando por la formula (I): en donde R1 y R2 son cada uno un atomo de hidrogeno , un atomo de halogeno, o un grupo hidrocarburo lineal opcionalmente substituido ; el anillo A es un anillo benceno opcionalmente ademas substituido, el anillo B es un anillo benceno opcionalmente substituido; R es un grupo carboxilo o un grupo hidrocarburo lineal con un grupo carboxilo y similares.
CR8577A 2004-03-02 2006-08-29 Derivados de coumarina y su uso CR8577A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004057920 2004-03-02

Publications (1)

Publication Number Publication Date
CR8577A true CR8577A (es) 2007-01-17

Family

ID=34909071

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8577A CR8577A (es) 2004-03-02 2006-08-29 Derivados de coumarina y su uso

Country Status (16)

Country Link
US (1) US7541478B2 (es)
EP (1) EP1720850A1 (es)
JP (1) JP2007526237A (es)
KR (1) KR20060130189A (es)
CN (1) CN1950352A (es)
AU (1) AU2005217335A1 (es)
BR (1) BRPI0508260A (es)
CA (1) CA2557162A1 (es)
CR (1) CR8577A (es)
IL (1) IL177105A0 (es)
NO (1) NO20064398L (es)
RU (1) RU2006134614A (es)
TW (1) TW200531969A (es)
UA (1) UA84052C2 (es)
WO (1) WO2005082879A1 (es)
ZA (1) ZA200606598B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2920774B1 (fr) 2007-09-06 2009-10-30 Galderma Res & Dev Nouveaux derives de n-phenul acatamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant
CN103788043B (zh) * 2008-11-28 2016-02-03 中国医学科学院药物研究所 硝克柳胺化合物晶iv型、其制法和其药物组合物与用途
CN112898342A (zh) * 2017-06-26 2021-06-04 上海日馨生物科技有限公司 苯磷硫胺衍生物、制备方法及其药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179904C (no) * 1992-09-04 1997-01-08 Takeda Chemical Industries Ltd Kondenserte heterocykliske forbindelser og deres anvendelse
JP2002255808A (ja) * 2000-07-13 2002-09-11 Takeda Chem Ind Ltd リピド・リッチ・プラーク退縮剤
IL153633A0 (en) * 2000-07-13 2003-07-06 Takeda Chemical Insustries Ltd Lipid-rich plaque inhibitors
IL162810A0 (en) * 2002-01-11 2005-11-20 Takeda Pharmaceutical coumarin derivatives, process for their productionand use thereof

Also Published As

Publication number Publication date
NO20064398L (no) 2006-11-08
WO2005082879A1 (en) 2005-09-09
BRPI0508260A (pt) 2007-07-31
US20070197636A1 (en) 2007-08-23
IL177105A0 (en) 2006-12-10
US7541478B2 (en) 2009-06-02
CA2557162A1 (en) 2005-09-09
CN1950352A (zh) 2007-04-18
TW200531969A (en) 2005-10-01
ZA200606598B (en) 2008-02-27
RU2006134614A (ru) 2008-04-10
JP2007526237A (ja) 2007-09-13
KR20060130189A (ko) 2006-12-18
EP1720850A1 (en) 2006-11-15
UA84052C2 (ru) 2008-09-10
AU2005217335A1 (en) 2005-09-09

Similar Documents

Publication Publication Date Title
AR034985A1 (es) Compuesto biciclico; produccion y uso del mismo
UY30499A1 (es) Derivados de amina utiles como agentes anticancerigenos
RS52168B (en) PIPERIDINSKI GPCR AGONIST
UY31604A1 (es) Compuestos tricíclicos y uso de los mismos
RS51943B (en) PIPERIDINSKI GPCR AGONIST
CY1120477T1 (el) Ενεργοποιητης του υποδοχεα που ενεργοποιειται απο πολλαπλασιαστες των υπεροξεισωματων
PE20061297A1 (es) Compuestos derivados de cromano y cromeno moduladores del receptor de serotonina 5-ht2c
CR10784A (es) Nuevos derivados de aminopirimidina como inhibidores de plki
RS51654B (en) DERIVATIVES OF THE SUBSTITUTED BICYCLIC PIRIMIDONE
EA202190654A1 (ru) Гетероциклическое соединение
CO6321130A2 (es) Piridinas carboxamidas como inhibidores de la 11 beta-hsd1
AR052915A1 (es) Derivados de pirrolidin y piperidin acetileno
AR075084A1 (es) Metodo de preparacion de quinolinil -oxidifenil - ciclopropanodicarboxamidas e intermediarios correspondientes
PE20130375A1 (es) Compuestos de triazolopiridinas y triazolopirazinas inhibidores de c-met y composiciones de los mismos
ECSP055974A (es) Síntesis de cloruros de 4 amino-2-butenoil y su uso en la preparación de 3-ciano quinolinas
AR057914A1 (es) Compuestos organicos de azufre y su uso
ES2422299T3 (es) Indoles (4,5-dihidro) indoles tricíclicos
AR058562A1 (es) Derivados de pirimido [4,5 b] (1,4) oxazinas , procedimientos de obtencion y su uso como inhibidores de acetil coa y dgat 1
CO6150142A2 (es) Bezoxazoles y oxazolopiridinas que son utiles como inhibidores de las cinasas janus
AR068366A1 (es) N-alquil-2-alquiltio-2-(heteroariloxi sustituido)-alquilamidas con actividad fungicida
RS53503B1 (en) AMORPHIC AND CRYSTAL FORM GENZ 112638 HEMITARTARATE AS A GLYCOSILKERAMIDE SYNTHASIS INHIBITOR
AR064521A1 (es) Activador de glucoquinasa
UY31014A1 (es) Derivados de ftalazinona
BR112014011064A8 (pt) derivados de antibióticos 2-oxo-oxazolidin-3,5-diila
MX2009007954A (es) Derivado de heterocicliden-n-(aril) acetamida.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)